Special Populations: Summary of the Discussion
Special populations need to be investigated to enable valid prescribing information in these patients to be given to the medical practitioner. The risk/benefit ratio was generally considered not to be uniform for all sectors of the population. Efficacy was not generally regarded as being in debate, but it was considered that the toxicological pro-file could vary with sectors of the population.
KeywordsData Sheet Legal Document Scientific Thinking Drug Interaction Study Marketing Approval
Unable to display preview. Download preview PDF.